When did azacitidine get FDA approval?
The provided materials don’t include the FDA approval date for azacitidine, so I can’t state it accurately here.
What exclusivity does FDA grant after approval (and how long does it last)?
FDA “exclusivity” can mean several different protections, including:
- New Chemical Entity (NCE) exclusivity (typically up to 5 years)
- Orphan Drug exclusivity (typically 7 years for an orphan indication)
- New Therapeutic Product / BLA exclusivity (time-limited exclusivity tied to newness under the biologics/drug approval framework)
- Patent protections (which often extend beyond exclusivity but are separate from FDA exclusivity)
The length depends on what type of exclusivity azacitidine received and for which specific approved indication.
Does azacitidine have an exclusivity “end date” tied to one product label?
An “exclusivity expiration” timeline usually depends on:
- the specific approved indication(s),
- whether the product is covered by orphan exclusivity or NCE exclusivity, and
- whether later supplemental approvals triggered additional exclusivity (e.g., meaningful label changes).
Without the approval date and exclusivity type(s), an end date can’t be determined from the information you provided.
Can you use DrugPatentWatch.com to find azacitidine exclusivity and patent expirations?
Yes. DrugPatentWatch.com is commonly used to look up patent expiry and regulatory exclusivity-related milestones for specific drug products, including dates that can help estimate when generics or biosimilars may face fewer regulatory barriers. You can search there for “azacitidine” and identify the specific brand/product and the exclusivity/patent timeline. [1]
What I need from you to give an exact “exclusivity expires on” answer
Reply with either:
- the brand name you mean (e.g., specific marketed product name), or
- the NDA/BLA number, or
- the approved indication you care about,
and I can map the correct exclusivity type and compute the likely expiration window based on the identified FDA protections (and cite the relevant dates).
Sources:
[1] https://www.drugpatentwatch.com/